An updated overview: Drug carriers used for the targeted delivery system

Kaur Ramandeep; Kaur Jasveer; Kaur Gurpreet; Saini Ritika; Kaur Chamanpreet; Kumar Sandeep

doi:10.53730/ijhs.v6nS5.10090

Authors

Kaur Ramandeep
raman1604503017@gmail.com
Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (Ropar) 140111, Punjab, India
Kaur Jasveer Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (Ropar) 140111, Punjab, India
Kaur Gurpreet Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (Ropar) 140111, Punjab, India
Saini Ritika Department of Pharmaceutics, Laurette Institue of Pharmacy Kathog Jawalamukhi Distt.Kangra-176031
Kaur Chamanpreet Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (Ropar) 140111, Punjab, India
Kumar Sandeep Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (Ropar) 140111, Punjab, India

Keywords:

Chemotherapeutic drugs, Targeted drug delivery system, Conventional drug delivery system, Drug carriers, Site-specific action, Nano-carriers

Abstract

In this high-tech era, the targeted drug delivery system has various progressions in the delivery of cancerous drugs. In the current review, the main purpose is to address the valuable needs of a targeted drug delivery system in all aspects of the safety and therapeutic delivery of drugs. The main objective is to introduce the drug carriers with their benefits. The targeted drug delivery system is superior to the traditional drug delivery system because they overcome the pros and cons and deliver the dosage form at the targeted site without exhibiting any side effects. The positive benefit of this system is that they reduce the dose dumping and provides the optimized delivery of drugs. The current review article elaborates on the different drug carriers used in the targeted drug delivery system such as liposomes, microspheres, and nanoparticles with their importance, merits, and demerits. This article mainly concentrates on the applications and some other important facts related to the targeted drug delivery carriers.

Downloads

Download data is not yet available.

References

Kumar A, Nautiyal U, Kaur C, Goel V, Piarchand N. Targeted drug delivery system: current and novel approach. Int J Pharm Med Res. 2017;5(2):448–454.

Kwon IK, Lee SC, Han B, Park K. Analysis on the current status of targeted drug delivery to tumors. J Control Release. 2012;164:108–114. doi:10.1016/j.jconrel.2012.07.010.

Gujral SS., Khatri S., A review on basic concept of drug targeting and drug carrier system, IJAPBC 2013;2:1.

Muller RH., Keck CM., Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles, Journal of Biotechnology 2004;113:1–3:151-170.

Vyas SP., Khar RK., Basis of targeted Drug Delivery. In Targeted and controlled Drug Delivery, CBS Publishers and Distributors Reprint 2008:42-46:74.

Jain NK., Controlled and Novel Drug Delivery, CBS publication, New delhi, 1st edition reprint 2008;100- 130,147-170, 304-352.

Vyas and Khar., Targeted and Controlled drug delivery (CBS Publishers and distributors 2001.

Mills JK, Needham D. Targeted drug delivery. Expert Opin Ther Pat. 1999;9(11):1499-513.

Torchilin VP. Drug targeting. Eur J Pharm Sci. 2000;11:S81-91.

Bae YH, Park K. Targeted drug delivery to tumors: Myths, reality and possibility. J Controlled Release. 2011;153(3):198.

Mills JK, Needham D. Targeted drug delivery. Expert Opin Ther Pat. 1999;9(11):1499-513.

Chrai SS, Murari R, Imran A: Liposomes: a review. Bio Pharm 2001, 14(11):10–14.

Himanshu A, Sitasharan P, Singhai AK: Liposomes as drug carriers. IJPLS 2011, 2(7):945–951.

Kataria S, Sandhu P, Bilandi A, Akanksha M, Kapoor B, Seth GL, Bihani SD: Stealth liposomes: a review. IJRAP 2011, 2(5):1534–1538.

Hamilton RL, Guo LSS: Liposomes preparation methods. J Clin Biochem Nut 1984, 7: 175.

Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR. Niosomes: Novel sustained release nonionic stable vesicular systems—an overview. Adv Colloid Interface Sci. 2012;183:46-54.

Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J Controlled Release. 2014;185:22-36.

Pravinagurjar N, Chouksey S. Niosome: A promising pharmaceutical drug delivery. Int J Pharm Drug Anal. 2014;2:425-31.

Hargreaves WR, Deamer DW. Liposomes from ionic, single-chain amphiphiles. Biochemistry 1978;17:3759-68.

Patel DM, Jani RH, Patel CN. Ufasomes: A Vesicular Drug Delivery. Systematic Reviews in Pharmacy. 2011; 2(2): 72-78.

George A, Nair SC. Ufasome: A potential phospholipid as a novel pharmaceutical formulation. Int. Res. J. Pharm. 2014. 5(4): 250- 253.

Jain S, Mahajan SC. Lipid based vesicular drug delivery system. Advances in Pharmaceutics. 2014: 1-12.

Patel SA. Review on ufasomes and vesicular drug delivery system. The Pharma Research. 2013; 9(01): 32-43..

Semalty A, Semalty M, Rawat BS, Singh D, Rawat MSM. Pharmacosomes: The lipid-based new drug delivery system. Expert Opin Drug Deliv. 2009;6(6):599-612.

Semalty A, Semalty M, Rawat BS, Singh D, Rawat MSM. Development and evaluation of pharmacosomes of aceclofenac. Indian J Pharm Sci. 2010;72(5):576.

Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, et al. The virosome concept for influenza vaccines. Vaccine. 2005;23:S26-38.

Cusi MG. Applications of influenza virosomes as a delivery system. Hum Vaccin. 2006;2(1):1-7.

Agnihotri J, Saraf S, Khale A. Targeting: New potential carriers for targeted drug delivery system. Int J Pharm Sci Rev Res. 2011;8(2):117-123.

Chaurasiya P., Ganju E., Upmanyu N., Ray S.K., Jain P. Transfersomes: A novel technique for transdermal drug delivery. J. Drug Deliv. Ther. 2019;9:279–285. doi: 10.22270/jddt.v9i1.2198.

Modi C., Bharadia P. Transfersomes: New dominants for transdermal drug delivery. Am. J. PharmTech. Res. 2012;2:71–91.

Jain A.K., Kumar F. Transfersomes: Ultradeformable vesicles for transdermal drug delivery. Asian J. Biomater. Res. 2017;3:1–13.

Garg G, Saraf S, Saraf S. Cubosomes: An overview. Biol Pharm Bull. 2007;30(2):350-3.

Azhari H, Strauss M, Hook S, Boyd BJ, Rizwan SB. Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood– brain barrier. Eur J Pharm Biopharm. 2016;104:148-55.

Mali S. Nanorobots: Changing face of healthcare system. Austin J Biomed Eng. 2014;1(3):3.

Thangavel K, Balamurugan A, Elango M, Subiramaniyam P, Senrayan M. A survey on nano-robotics in nano-medicine. Nanotechnology. 2014;8:9.

Andhari SS, Wavhale RD, Dhobale KD, Tawade BV, Chate GP, Patil YN, et al. Self-propelling targeted Magneto-nanobots for Deep tumor penetration and pH-Responsive intracellular Drug Delivery. Sci Rep. 2020;10(1):1-16.

Suryanarayana C, Froes FH. The structure and mechanical properties of metallic nanocrystals. Metall Trans A. 1992;23(4):1071-81.

Elazzouzi-Hafraoui S, Nishiyama Y, Putaux JL, Heux L, Dubreuil F, Rochas C. The shape and size distribution of crystalline nanoparticles prepared by acid hydrolysis of native cellulose. Biomacromolecules. 2008;9(1):57-65.

Liu F, Park JY, Zhang Y, Conwell C, Liu Y, Bathula SR, et al. Targeted cancer therapy with novel high drug-loading nanocrystals. J Pharm Sci. 2010;99(8):3542-551.

K. Pal, A. K. Banthia, and D. K. Majumdar, ―Preparation and characterization of polyvinyl alcohol-gelatin hydrogel membranes for biomedical applications,‖ AAPS PharmSciTech, 2007; 8: 1.

T. R. Hoare and D. S. Kohane, "Hydrogels in drug delivery: Progress and challenges," Polymer, 2008; 49(8): 1993–2007.

Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteom. 2009;6(3):267– 83. https ://doi.org/10.1586/epr.09.17.

Kanaparthy R, Kanaparthy A. The changing face of dentistry: Nanotechnology. Int J Nanomedicine. 2011;6:2799.

Nagda D, Rathore KS, Bharkatiya M, Sisodia SS, Nema RK. Bucky balls: A novel drug delivery system. J Chem Pharm RES. 2010;2:240-3.

Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 2004;22(8):969-76.

Pardo J, Peng Z, Leblanc RM. Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes. Molecules. 2018;23(2):378.

Thaxton CS, Georganopoulou DG, Mirkin CA. Gold nanoparticle probes for the detection of nucleic acid targets. Clin Chim Acta. 2006;363(1-2):120-6.

Huang X, O’Connor R, Kwizera EA. Gold nanoparticle based platforms for circulating cancer marker detection. Nanotheranostics. 2017;1(1):80.

Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O’Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006;7(8):657-67.

Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol. 2009;4(10):669-73.

Rakhmonov, O. M., Shadmanov, A. K., & Juraev, F. M. (2021). Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome. International Journal of Health & Medical Sciences, 5(1), 21-25. https://doi.org/10.21744/ijhms.v5n1.1811

Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK. Dendrimers: Emerging polymers for drug-delivery systems. Eur J Pharm Sci. 2009;38(3):185-96.

Garg T, Singh O, Arora S, Murthy R. Dendrimer: A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 2011;7(2):211-20.

Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev. 2012;64:102-15.

Balogh L, Bielinska A, Eichman JD, Valluzzi R, Lee I, Baker JR, et al. Dendrimer nanocompositer in medicine. Chim Oggi. 2002;20(5):35-40.

Shinkar, DM, Bhamare, BS, Saudagar, RB. Microsponges. Asian Journal of Research in Pharmaceutical Sciences 2016;6(2):2231- 59.

Chowdary, KP, R, Rao, SY. Mucoadhesive microspheres for controlled drug delivery. Biological and Pharmaceutical Bulletin 2004;27(11):1717–24.

Chadawar, V, Shaji, J. Microsponge delivery system. Current Drug Delivery 2007:4(2):123–9.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Zaki-Rizkalla, CM, Latif-Aziz, R, Soliman. In vitro and in vivo evaluation of hydroxyzine hydro ride microsponges for topical delivery. American Association of Pharmaceutical Scientists 2011;12(3):989–1001.

Bolmal UB, Manvi FV, Rajkumar K, Palla SS, Paladugu A, Reddy KR. Recent advances in nanosponges as drug delivery system. Int J Pharm Sci Nanotechnol 2013;6:1934-44.

Shivani S, Poladi KK. Nanosponges-novel emerging drug delivery system: a review. Int J Pharm Sci Res 2015;6:529.

Thakre AR, Gholse YN, Kasliwal RH. Nanosponges: a novel approach of drug delivery system. J Med Pharm Allied Sci 2016;78